These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26002555)

  • 21. HLA ligand profiles of primary renal cell carcinoma maintained in metastases.
    Stickel JS; Weinzierl AO; Hillen N; Drews O; Schuler MM; Hennenlotter J; Wernet D; Müller CA; Stenzl A; Rammensee HG; Stevanović S
    Cancer Immunol Immunother; 2009 Sep; 58(9):1407-17. PubMed ID: 19184600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MDR1 RNA levels in human renal cell carcinomas: correlation with grade and prediction of reversal of doxorubicin resistance by quinidine in tumor explants.
    Kanamaru H; Kakehi Y; Yoshida O; Nakanishi S; Pastan I; Gottesman MM
    J Natl Cancer Inst; 1989 Jun; 81(11):844-9. PubMed ID: 2724349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a realistic in vivo bone metastasis model of human renal cell carcinoma.
    Valta MP; Zhao H; Ingels A; Thong AE; Nolley R; Saar M; Peehl DM
    Clin Exp Metastasis; 2014 Jun; 31(5):573-84. PubMed ID: 24715498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TP53 alterations in pancreatic acinar cell carcinoma: new insights into the molecular pathology of this rare cancer.
    La Rosa S; Bernasconi B; Frattini M; Tibiletti MG; Molinari F; Furlan D; Sahnane N; Vanoli A; Albarello L; Zhang L; Notohara K; Casnedi S; Chenard MP; Adsay V; Asioli S; Capella C; Sessa F
    Virchows Arch; 2016 Mar; 468(3):289-96. PubMed ID: 26586531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma.
    Nassar AH; Hamieh L; Gray KP; Thorner AR; Fay AP; Lasseter KD; Abou Alaiwi S; Nuzzo PV; Flippot R; Krajewski KM; Signoretti S; Choueiri TK; Kwiatkowski DJ
    Mol Cancer Ther; 2020 Feb; 19(2):690-696. PubMed ID: 31653662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p53 isoform expression in renal cell carcinoma.
    van den Berg L; Segun AD; Mersch S; Blasberg N; Grinstein E; Wai D; Anlauf M; Gabbert HE; Mahotka C; Heikaus S
    Front Biosci (Elite Ed); 2010 Jun; 2(3):1042-53. PubMed ID: 20515774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell-cycle arrest and senescence in TP53-wild type renal carcinoma by enhancer RNA-P53-bound enhancer regions 2 (p53BER2) in a p53-dependent pathway.
    Xie H; Ma K; Zhang K; Zhou J; Li L; Yang W; Gong Y; Cai L; Gong K
    Cell Death Dis; 2021 Jan; 12(1):1. PubMed ID: 33414393
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-regional sequencing reveals clonal and polyclonal seeding from primary tumor to metastases in advanced gastric cancer.
    Hirotsu Y; Hada M; Amemiya K; Oyama T; Mochizuki H; Omata M
    J Gastroenterol; 2020 May; 55(5):553-564. PubMed ID: 31912238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Review of prognostic and predictive aspects of mutated TP53 in Wilms' tumor biology with morphological report and molecular analysis of 37-year-old man's nephroblastoma.
    Wincewicz A; Kowalik A; Zięba S; Kopczyński J; Góźdź S; Sulkowski S
    Pol J Pathol; 2016; 67(4):307-312. PubMed ID: 28547957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].
    Junker K; Steiner T; Sanjmyatav J; Pilchowski R; Heinze C; Walter M; Schubert J
    Pathologe; 2009 Mar; 30(2):105-10. PubMed ID: 19089427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular analysis of primary and metastatic sites in patients with renal cell carcinoma.
    Gulati S; Barata PC; Elliott A; Bilen MA; Burgess EF; Choueiri TK; Darabi S; Dawson NA; Gartrell BA; Hammers HJ; Heath EI; Magee D; Rao A; Ryan CJ; Twardowski P; Wei S; Brugarolas J; Zhang T; Zibelman MR; Nabhan C; McKay RR
    J Clin Invest; 2024 May; 134(14):. PubMed ID: 39007269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the invasive and metastatic phenotype in human renal cell carcinoma.
    Saiki I; Naito S; Yoneda J; Azuma I; Price JE; Fidler IJ
    Clin Exp Metastasis; 1991; 9(6):551-66. PubMed ID: 1752085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic tropism of metastatic renal cell carcinoma.
    Singla N; Xie Z; Zhang Z; Gao M; Yousuf Q; Onabolu O; McKenzie T; Tcheuyap VT; Ma Y; Choi J; McKay R; Christie A; Torras OR; Bowman IA; Margulis V; Pedrosa I; Przybycin C; Wang T; Kapur P; Rini B; Brugarolas J
    JCI Insight; 2020 Apr; 5(7):. PubMed ID: 32271170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The T963C mutation of TP53 gene does not participate in the clonal origin of canine TVT.
    Vázquez-Mota N; Simón-Martínez J; Córdova-Alarcon E; Lagunes L; Fajardo R
    Vet Res Commun; 2008 Feb; 32(2):187-91. PubMed ID: 17668284
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multiple metastatic clones assessed by an integrative multiomics strategy in clear cell renal carcinoma: a case study.
    Dagher J; Brunot A; Evrard B; Kammerer-Jacquet SF; Beaumont M; Cornevin L; Derquin F; Verhoest G; Bensalah K; Lespagnol A; Dugay F; Belaud-Rotureau MA; Chalmel F; Rioux-Leclercq N
    J Clin Pathol; 2022 Jun; 75(6):426-430. PubMed ID: 33766955
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumour heterogeneity in triplet-paired metastatic tumour tissues in metastatic renal cell carcinoma: concordance analysis of target gene sequencing data.
    Kim SH; Park WS; Chung J
    J Clin Pathol; 2019 Feb; 72(2):152-156. PubMed ID: 30409839
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transient commensal clonal interactions can drive tumor metastasis.
    Naffar-Abu Amara S; Kuiken HJ; Selfors LM; Butler T; Leung ML; Leung CT; Kuhn EP; Kolarova T; Hage C; Ganesh K; Panayiotou R; Foster R; Rueda BR; Aktipis A; Spellman P; Ince TA; Xiu J; Oberley M; Gatalica Z; Navin N; Mills GB; Bronson RT; Brugge JS
    Nat Commun; 2020 Nov; 11(1):5799. PubMed ID: 33199705
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Particular gene upregulation and p53 heterogeneous expression in
    Kudo I; Esumi M; Kusumi Y; Furusaka T; Oshima T
    Oncol Lett; 2017 Oct; 14(4):4633-4640. PubMed ID: 29085461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroblastoma-associated Renal Cell Carcinoma: A Case Report and Review of the Literature.
    Ogunbiyi MO; Rodriguez-Justo M; Gaunt T; Shankar A
    J Pediatr Hematol Oncol; 2022 Mar; 44(2):e612-e615. PubMed ID: 34310473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tracing Renal Cell Carcinomas back to the Nephron.
    Lindgren D; Sjölund J; Axelson H
    Trends Cancer; 2018 Jul; 4(7):472-484. PubMed ID: 29937046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.